Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier BV in Epilepsy & Behavior
- Vol. 103, 106864
- https://doi.org/10.1016/j.yebeh.2019.106864
Abstract
No abstract availableKeywords
Funding Information
- UCB Pharma
This publication has 33 references indexed in Scilit:
- Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studiesNeurology, 2016
- Bioavailability and bioequivalence comparison of brivaracetam 10, 50, 75, and 100 mg tablets and 100 mg intravenous bolusEpilepsia, 2016
- Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsyEpilepsia, 2016
- A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizuresEpilepsia, 2015
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double‐blind, placebo‐controlled trialEpilepsia, 2013
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double‐blind, randomized, placebo‐controlled trialEpilepsia, 2013
- Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double‐blind, randomized, placebo‐controlled, flexible‐dose trialEpilepsia, 2013
- Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial‐onset seizures: A phase IIb, randomized, controlled trialEpilepsia, 2012
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant propertiesEuropean Journal of Pharmacology, 2011
- Adjunctive brivaracetam for refractory partial-onset seizuresNeurology, 2010